These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29399388)

  • 21. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Nov; 177(9):6018-24. PubMed ID: 17056526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.
    Kriegsman BA; Vangala P; Chen BJ; Meraner P; Brass AL; Garber M; Rock KL
    J Immunol; 2019 Oct; 203(7):1999-2010. PubMed ID: 31471524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome.
    Oliveira CC; van Hall T
    Front Immunol; 2015; 6():298. PubMed ID: 26097483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
    Durgeau A; El Hage F; Vergnon I; Validire P; de Montpréville V; Besse B; Soria JC; van Hall T; Mami-Chouaib F
    J Immunol; 2011 Dec; 187(11):5532-9. PubMed ID: 22025554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1
    Doorduijn EM; Sluijter M; Querido BJ; Seidel UJE; Oliveira CC; van der Burg SH; van Hall T
    Front Immunol; 2018; 9():60. PubMed ID: 29422902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TEIPP peptides: exploration of unTAPped cancer antigens.
    Marijt KA; Van Der Burg SH; van Hall T
    Oncoimmunology; 2019; 8(8):1599639. PubMed ID: 31413908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
    van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
    J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
    El Hage F; Durgeau A; Mami-Chouaib F
    Ann N Y Acad Sci; 2013 Apr; 1283():75-80. PubMed ID: 23302073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAP-Dependent and -Independent Peptide Import into Dendritic Cell Phagosomes.
    Lawand M; Abramova A; Manceau V; Springer S; van Endert P
    J Immunol; 2016 Nov; 197(9):3454-3463. PubMed ID: 27664280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.
    Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB
    J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes.
    Clarke SR; Rudensky AY
    J Immunol; 2000 Sep; 165(5):2458-64. PubMed ID: 10946271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
    Steinman RM
    Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.